Telemetry Investments, L.L.C. Karyopharm Therapeutics Inc. Transaction History
Telemetry Investments, L.L.C.
- $63.3 Million
- Q4 2022
A detailed history of Telemetry Investments, L.L.C. transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 50,000 shares of KPTI stock, worth $208,000. This represents 0.15% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$208,000% of portfolio
0.15%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding KPTI
# of Institutions
94Shares Held
59.6MCall Options Held
547KPut Options Held
67K-
Vanguard Group Inc Valley Forge, PA7.65MShares$31.8 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.32MShares$26.3 Million0.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA4.91MShares$20.4 Million0.53% of portfolio
-
Black Rock Inc. New York, NY4.17MShares$17.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.51MShares$14.6 Million0.0% of portfolio
About Karyopharm Therapeutics Inc.
- Ticker KPTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,806,600
- Market Cap $332M
- Description
- Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...